The billions of prescriptions filled each year in the United States challenge payers' and providers' abilities to conduct effective billing reviews and audits. This is no small concern, as improper billing practices unnecessarily drain the entire healthcare system of hard-earned financial resources.
Electronic billing and auditing systems represent a vast improvement over paper-based practices, especially when they draw on a drug database that flexibly brings together reliable clinical and drug-pricing information. First DataBank's
National Drug Data File Plus (NDDF Plus) is the most comprehensive and widely used drug data base in the healthcare industry. Our use in payer and provider systems throughout the country is a clear indication of the trust we've earned in our 25 years as a pioneering industry leader.
Supporting Accurate Financial Reporting
Due to the enormous volume associated with drug billing transactions, it's essential that payers and providers audit these transactions for fraud and mistakes. Because our drug databases are so widely used—and because they offer comprehensive, up-to-date drug content integrated with clinical decision-support modules—First DataBank enables more efficient tracing and auditing of these transactions.
In particular, our
Multiple Access Points or
MAPs are a complete drug vocabulary that employs recognized best practices to advance stability and minimize change management. The variety and flexibility of drug descriptors enable users to zero in on the information they're seeking quickly and accurately. Built-in relationships between vocabulary items facilitate improved tracking and communication.
Cost-Effective Drug Therapy Management
First DataBank products also facilitate drug therapy management. They enhance formulary management, and automate screening processes that detect duplicate therapies, drug interactions, and dosing miscalculations. User-friendly access to multiple logical therapeutic classification systems, the breadth and depth of our drug vocabulary and detailed sets of data elements for supporting informed decisions allow you to quickly research current pricing, easily search for the lowest-cost drug within a given therapeutic class, and compare brand name and generic drugs.ponents, First DataBank sets the standard for providing user-centric drug information for hospitals and IDNs.
Essential Building Blocks
In short, by drawing on the following components, First DataBank sets the standard for providing user-centric drug information for medication billing review and auditing.
NDDF Plus is the leader in supplying comprehensive coverage of descriptive, pricing and clinical information on drugs. It encompasses medications approved by the FDA, plus commonly used over-the-counter drugs and information on herbals, nutraceuticals, dietary supplements, and medical devices.
Comprehensive and up-to-date are the key concepts here, since drug content is dynamic and notoriously complex to maintain. It's essential, therefore, that the drug database behind your billing review and auditing applications be the most reliable in the industry. NDDF Plus is that database. It also offers you the most efficient ways of navigating to exactly the information you need for the task at hand, allowing for more informed decision-making, fewer medication errors and increased patient safety.
MAPs are the flexible, user-centric drug identifiers that enable all users to zero in on First DataBank drug information quickly and efficiently within their normal workflow.
Formulist provides unprecedented drug pricing analysis and drug formulary management capabilities through a user-friendly interface that draws on the over 100,000 drug and healthcare products in NDDF Plus, as well as the power of our proprietary Enhanced Therapeutic Classification (ETC) system. Compatible with virtually all industry IT standards, Formulist takes advantage of the latest software advances.
PricePoint Rx delivers authoritative drug price information in seconds, using an intuitive design that allows you to look up current and historical pricing, and easily review products and prices.
Our clinical modules for drug-drug, drug-allergy, drug-disease, duplicate therapy, drug-food interactions and other clinical decision-support functions offer exceptionally flexible ways for you to create applications that identify and display potentially harmful interactions. First DataBank's dedicated clinical staff separates these interactions into highly granular categories, and then carefully and consistently creates subsets of the most clinically relevant drug interactions. This reduces "noise" that less relevant interactions produce, and eliminates the need for clinicians to spend undue time researching interactions.